True Link Financial Advisors, LLC Pfizer Inc Transaction History

True Link Financial Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	BUY	$32.09 - $37.51 $6,418 - $7,502	200 Added 1.66%	12,283 $407,000
Q1 2023 May 05, 2023	SELL	$39.39 - $51.28 $7,562 - $9,845	-192 Reduced 1.56%	12,083 $492,000
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $157,536 - $192,312	3,600 Added 41.5%	12,275 $537,000
Q2 2022 Aug 04, 2022	BUY	$46.53 - $55.17 $10,841 - $12,854	233 Added 2.76%	8,675 $455,000
Q4 2021 Feb 01, 2022	BUY	$41.32 - $61.25 $136,356 - $202,125	3,300 Added 64.18%	8,442 $499,000
Q2 2021 Aug 19, 2021	BUY	$35.91 - $40.68 $8,690 - $9,844	242 Added 4.94%	5,142 $201,000
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $5,023 - $5,665	150 Added 3.16%	4,900 $178,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $158,982 - $202,160	4,750 New	4,750 $175,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of True Link Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on True Link Financial Advisors, LLC with notifications on news.